661 related articles for article (PubMed ID: 32990503)
1. Faecal microbiota transplantation for
Terveer EM; Vendrik KE; Ooijevaar RE; Lingen EV; Boeije-Koppenol E; Nood EV; Goorhuis A; Bauer MP; van Beurden YH; Dijkgraaf MG; Mulder CJ; Vandenbroucke-Grauls CM; Seegers JF; van Prehn J; Verspaget HW; Kuijper EJ; Keller JJ
United European Gastroenterol J; 2020 Dec; 8(10):1236-1247. PubMed ID: 32990503
[TBL] [Abstract][Full Text] [Related]
2. Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience.
Pipek B; Valentová H; Fojtík P; Urban O
Cas Lek Cesk; 2022; 161(3-4):126-130. PubMed ID: 36100450
[TBL] [Abstract][Full Text] [Related]
3. A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group.
Keller JJ; Ooijevaar RE; Hvas CL; Terveer EM; Lieberknecht SC; Högenauer C; Arkkila P; Sokol H; Gridnyev O; Mégraud F; Kump PK; Nakov R; Goldenberg SD; Satokari R; Tkatch S; Sanguinetti M; Cammarota G; Dorofeev A; Gubska O; Ianiro G; Mattila E; Arasaradnam RP; Sarin SK; Sood A; Putignani L; Alric L; Baunwall SMD; Kupcinskas J; Link A; Goorhuis AG; Verspaget HW; Ponsioen C; Hold GL; Tilg H; Kassam Z; Kuijper EJ; Gasbarrini A; Mulder CJJ; Williams HRT; Vehreschild MJGT
United European Gastroenterol J; 2021 Mar; 9(2):229-247. PubMed ID: 33151137
[TBL] [Abstract][Full Text] [Related]
4. Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).
Minkoff NZ; Aslam S; Medina M; Tanner-Smith EE; Zackular JP; Acra S; Nicholson MR; Imdad A
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013871. PubMed ID: 37096495
[TBL] [Abstract][Full Text] [Related]
5. Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection.
Brown JR; Flemer B; Joyce SA; Zulquernain A; Sheehan D; Shanahan F; O'Toole PW
BMC Gastroenterol; 2018 Aug; 18(1):131. PubMed ID: 30153805
[TBL] [Abstract][Full Text] [Related]
6. Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT): a randomised, double-blind, placebo-controlled trial.
Baunwall SMD; Andreasen SE; Hansen MM; Kelsen J; Høyer KL; Rågård N; Eriksen LL; Støy S; Rubak T; Damsgaard EMS; Mikkelsen S; Erikstrup C; Dahlerup JF; Hvas CL
Lancet Gastroenterol Hepatol; 2022 Dec; 7(12):1083-1091. PubMed ID: 36152636
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
Khanna S; Assi M; Lee C; Yoho D; Louie T; Knapple W; Aguilar H; Garcia-Diaz J; Wang GP; Berry SM; Marion J; Su X; Braun T; Bancke L; Feuerstadt P
Drugs; 2022 Oct; 82(15):1527-1538. PubMed ID: 36287379
[TBL] [Abstract][Full Text] [Related]
8. Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.
Kelly CR; Khoruts A; Staley C; Sadowsky MJ; Abd M; Alani M; Bakow B; Curran P; McKenney J; Tisch A; Reinert SE; Machan JT; Brandt LJ
Ann Intern Med; 2016 Nov; 165(9):609-616. PubMed ID: 27547925
[TBL] [Abstract][Full Text] [Related]
9. Reducing Cost and Complexity of Fecal Microbiota Transplantation Using Universal Donors for Recurrent Clostridium difficile Infection.
Kim KO; Schwartz MA; Lin OST; Chiorean MV; Gluck M
Adv Ther; 2019 Aug; 36(8):2052-2061. PubMed ID: 31154629
[TBL] [Abstract][Full Text] [Related]
10. Faecal microbiota transplantation for eradication of co-infection with
Bahl MI; Jørgensen SMD; Skriver AH; Larsen NA; Wang M; Licht TR; Dahlerup JF; Hvas CL
Scand J Gastroenterol; 2020 May; 55(5):626-630. PubMed ID: 32324085
[No Abstract] [Full Text] [Related]
11. Fecal Microbiota Transplantation for Recurrent Clostridioides difficile infection: The COVID-19 Era.
Khanna S; Pardi D
Am J Gastroenterol; 2020 Jul; 115(7):971-974. PubMed ID: 32618640
[No Abstract] [Full Text] [Related]
12. How to: Establish and run a stool bank.
Terveer EM; van Beurden YH; Goorhuis A; Seegers JFML; Bauer MP; van Nood E; Dijkgraaf MGW; Mulder CJJ; Vandenbroucke-Grauls CMJE; Verspaget HW; Keller JJ; Kuijper EJ
Clin Microbiol Infect; 2017 Dec; 23(12):924-930. PubMed ID: 28529025
[TBL] [Abstract][Full Text] [Related]
13. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
[TBL] [Abstract][Full Text] [Related]
14. Faecal microbiota transplantation as a home therapy to frail older people.
Jørgensen SMD; Rubak TMM; Damsgaard EM; Dahlerup JF; Hvas CL
Age Ageing; 2020 Oct; 49(6):1093-1096. PubMed ID: 32365381
[TBL] [Abstract][Full Text] [Related]
15. Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience.
Cheng YW; Phelps E; Ganapini V; Khan N; Ouyang F; Xu H; Khanna S; Tariq R; Friedman-Moraco RJ; Woodworth MH; Dhere T; Kraft CS; Kao D; Smith J; Le L; El-Nachef N; Kaur N; Kowsika S; Ehrlich A; Smith M; Safdar N; Misch EA; Allegretti JR; Flynn A; Kassam Z; Sharfuddin A; Vuppalanchi R; Fischer M
Am J Transplant; 2019 Feb; 19(2):501-511. PubMed ID: 30085388
[TBL] [Abstract][Full Text] [Related]
16. How to prepare stool banks for an appropriate response to the ongoing COVID-19 pandemic: Experiences in the Netherlands and a retrospective comparative cohort study for faecal microbiota transplantation.
Groenewegen B; van Lingen E; Ooijevaar RE; Wessels E; Feltkamp MCW; Boeije-Koppenol E; Verspaget HW; Kuijper EJ; van Prehn J; Keller JJ; Terveer EM;
PLoS One; 2022; 17(3):e0265426. PubMed ID: 35298520
[TBL] [Abstract][Full Text] [Related]
17. Systematic review with meta-analysis: long-term outcomes of faecal microbiota transplantation for Clostridium difficile infection.
Li YT; Cai HF; Wang ZH; Xu J; Fang JY
Aliment Pharmacol Ther; 2016 Feb; 43(4):445-57. PubMed ID: 26662643
[TBL] [Abstract][Full Text] [Related]
18. Fecal Microbiome Transplantation for Recurrent Clostridioides difficile Infection: Treatment Efficacy, Short and Long-term Follow-up Results from Consecutive Case Series.
Urbonas T; Ianiro G; Gedgaudas R; Sabanas P; Urba M; Kiudelis V; Kiudelis G; Petkevicius V; Vitkauskiene A; Cammarota G; Gasbarrini A; Kupcinskas J
J Gastrointestin Liver Dis; 2021 Dec; 30(4):470-476. PubMed ID: 34752587
[TBL] [Abstract][Full Text] [Related]
19. Faecal banking at -20 °C facilitates faecal microbiota transplantation for recurrent
Satokari R; Pietilä L; Mattila E; Lahtinen P; Arkkila PET
Infect Dis (Lond); 2020 Sep; 52(9):662-665. PubMed ID: 32516025
[No Abstract] [Full Text] [Related]
20. [Reconsidering the technical aspects and quality management background of faecal microbiota transplantation due to the novel coronavirus pandemic].
Nagy GG; Tudlik Z; Gergely L; Kónya J; Orosi P; Rákóczi É; Szabó J; Várvölgyi C; Vitális E; Paragh G
Orv Hetil; 2020 Nov; 161(44):1858-1871. PubMed ID: 33130602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
